http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23068002

Outgoing Links

Predicate Object
contentType Clinical Trial|Clinical Trial, Phase II|Journal Article|Multicenter Study
endingPage 814
issn 0007-0920
1532-1827
issueIdentifier 4
pageRange 810-814
publicationName British Journal of Cancer
startingPage 810
bibliographicCitation Guppy AE, Nelstrop AE, Foster T, Agarwal R, Seckl MJ, Rustin GJS. A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer. British Journal of Cancer. 2004 Feb 17;90(4):810–4. doi: 10.1038/sj.bjc.6601618.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_938dc1cd1cf25ee8cde00e14898c0d4b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c54210d2ec4690f7b5b6c449523e258a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_276b0eeeffbdab0130beccc156892a77
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3278ff35aabccec6549ca5b921c7b4b8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50b075a479008beb1fc10327ef55a366
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_adc2edb406baf684e9b2b6d57775b4ee
date 2004-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC2410185
https://doi.org/10.1038/sj.bjc.6601618
https://pubmed.ncbi.nlm.nih.gov/14970858
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
https://portal.issn.org/resource/ISSN/0007-0920
https://portal.issn.org/resource/ISSN/1532-1827
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer
discusses http://id.nlm.nih.gov/mesh/M0026156
http://id.nlm.nih.gov/mesh/M0029340
http://id.nlm.nih.gov/mesh/M0024707
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8752
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f23da35a23be1387249189adc219228a
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60700
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9002f7b62e7223e85a4962c6cd6d9c18
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID426756

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129108869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129423977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135867281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128364298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129347572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135808554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129046631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135789409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660

Total number of triples: 49.